Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $391.55 | 20 | 96.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14.28 | 1 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $100.73 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $95.79 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $83.81 | 4 | $0 (2024) |
| Abbott Laboratories | $47.15 | 2 | $0 (2024) |
| SANOFI PASTEUR INC. | $36.92 | 3 | $0 (2020) |
| Novo Nordisk Inc | $25.00 | 1 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $16.43 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.51 | 6 | AstraZeneca Pharmaceuticals LP ($95.79) |
| 2023 | $94.55 | 5 | GlaxoSmithKline, LLC. ($48.63) |
| 2022 | $54.81 | 3 | PFIZER INC. ($54.81) |
| 2021 | $38.61 | 2 | Abbott Laboratories ($22.42) |
| 2020 | $11.83 | 1 | SANOFI PASTEUR INC. ($11.83) |
| 2019 | $52.24 | 3 | Novo Nordisk Inc ($25.00) |
| 2018 | $14.28 | 1 | Sanofi Pasteur Inc. ($14.28) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $28.08 | General |
| 10/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.14 | General |
| 06/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Diabetes Care | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.03 | General |
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.54 | General |
| 11/01/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: VACCINES | ||||||
| 08/29/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: VACCINES | ||||||
| 01/11/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: VACCINES | ||||||
| 09/12/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: VACCINES | ||||||
| 04/22/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: VACCINES | ||||||
| 02/08/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: VACCINES | ||||||
| 11/15/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Diabetes Care | ||||||
| 03/05/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: VACCINES | ||||||
| 10/28/2020 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUZONE QUADRIVALENT, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Vaccines | ||||||
| 09/25/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 09/06/2019 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), FLUBLOK QUADRIVALENT, FLUZONE QUADRIVALENT | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: VACCINES | ||||||
| 01/26/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/10/2018 | Sanofi Pasteur Inc. | NO PRODUCT DISCUSSED (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $14.28 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 996 | 1,376 | $292,695 | $86,563 |
| 2022 | 15 | 1,041 | 1,383 | $265,000 | $83,032 |
| 2021 | 16 | 1,023 | 1,281 | $196,455 | $65,990 |
| 2020 | 15 | 1,021 | 1,300 | $199,470 | $58,789 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 303 | $122,715 | $28,797 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 120 | 120 | $30,000 | $17,020 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 243 | $70,470 | $15,133 | 21.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 55 | 81 | $28,350 | $6,884 | 24.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $11,300 | $5,629 | 49.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 279 | 355 | $6,055 | $2,975 | 49.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 37 | 37 | $5,550 | $2,651 | 47.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,900 | $2,349 | 60.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 72 | 72 | $5,040 | $1,503 | 29.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 43 | $1,720 | $1,455 | 84.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 27 | $4,725 | $1,204 | 25.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $1,300 | $676.80 | 52.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 23 | $1,380 | $243.96 | 17.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 19 | $190.00 | $41.80 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 263 | $106,515 | $25,836 | 24.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 132 | 132 | $27,500 | $19,254 | 70.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 241 | $69,890 | $16,091 | 23.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 49 | 67 | $23,450 | $6,341 | 27.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 17 | 17 | $8,075 | $4,738 | 58.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 48 | 48 | $7,200 | $3,290 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 53 | 54 | $2,160 | $1,819 | 84.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 65 | 65 | $4,020 | $1,370 | 34.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 270 | 356 | $5,340 | $1,053 | 19.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 16 | 22 | $3,565 | $903.39 | 25.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 23 | 25 | $1,625 | $848.58 | 52.2% |
About Dr. Devika Kommineni, MD
Dr. Devika Kommineni, MD is a Internal Medicine healthcare provider based in Marlborough, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801877741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devika Kommineni, MD has received a total of $405.83 in payments from pharmaceutical and medical device companies, with $139.51 received in 2024. These payments were reported across 21 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($391.55).
As a Medicare-enrolled provider, Kommineni has provided services to 4,081 Medicare beneficiaries, totaling 5,340 services with total Medicare billing of $294,373. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Marlborough, MA
- Active Since 11/08/2005
- Last Updated 10/30/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801877741
Products in Payments
- PREVNAR 20 (Biological) $100.73
- AREXVY (Drug) $67.62
- Tresiba (Drug) $25.00
- FREESTYLE LIBRE 3 (Device) $24.73
- FreeStyle Libre 2 (Device) $22.42
- NUPLAZID (Drug) $16.43
- SHINGRIX (Biological) $16.19
- NO PRODUCT DISCUSSED (Drug) $14.28
- FLUZONE HIGH-DOSE (Biological) $11.83
- FLUZONE HIGH-DOSE (Drug) $10.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Marlborough
Marguerite Brackley, M.d, M.D
Internal Medicine — Payments: $291,890
Shunian He, Md, MD
Internal Medicine — Payments: $9,899
Kathleen White, D.o, D.O
Internal Medicine — Payments: $3,625
Sangeetha Punjabi, Md, MD
Internal Medicine — Payments: $2,062
Lalita Matta, M.d, M.D
Internal Medicine — Payments: $986.61
Dolly Geevarghese, Md, MD
Internal Medicine — Payments: $743.99